4Patsalos PN.Clinical pharmacokinetics of levetiracetam[J].Clin Pharmacokinet,2004,43(11):707-724.
5Pina-Garzn JE,Schiemann-Delgado J,Yang H,et al.Adjunctive levertiracetam in patients aged 1 month to<4 years with partial onset seizures:subpopulation analysis of a prospective,open label extension study of up to 48 weeks[J].Clin Ther,2010,32(11):1935-1950.
6Furwentsches A,Bussmann C,Ramantani G,et al.Levertiracetam in the treatment of neonatal seizures:a pilot study[J].Seizure,2010,19(3):185-189.
7De Smedt T,Raedt R,Vonck K.Levertiracetam:partⅡ,the clinical profile of a novel anticonvulsant drug[J].CNS Drug Rev,2007,13(1):57-78.
4Carreno M,Donaire A,Sanchez-Carpintero B.Cognitive disorders associated with epilepsy:diagnosis and treatment[J].Neurologist,2008,14(6 Suppl 1):26-34.
5Fastenau PS,Johnson CS,Perkins SM,et al.Neuropsychological status at seizure onset in children:risk factors for early cognitive deficits[J].Neurology,2009,73(7):526-534.
6Hermann B,Jones J,Dabhs K,et al.The frequency,complications and aetiology of ADHD in new onset paediatric epilepsy[J].Brain,2007,130(Pt 12):3135-3148.
7Dabhs K,Jones J,Seidenberg M,et al.Neuroanatomical correlates of cognitive phenotypes in temporal lobe epilepsy[J].Epilepsy Behay,2009,15 (4):445-451.
8Aldonkamp AP,Bodde N.Behaviour,cognition and epilepsy[J].Acta Ncurol Scand Suppl,2005,182(1):19-25.
9Blumenfeld H,Varghese GI,Purcaro MJ,et al.Cortical and subcortical networks in human secondarily generalized tonic-clonic seizures[J].Brain,2009,132(Pt 4):999-1012.
10Galanopoulou AS,Moshe SL.The epileptic hypothesis:developmentally related arguments based on animal models[J].Epilepsia,2009,50(Suppl 7):37-42.
